English - Siegfried

More documents

Recommendations

Info

3.2 Participation structure of Siegfried Holding AG1. Switzerland Currency Share Capital in LC Participation CommentsSiegfried Ltd, Zofingen CHF 20 000 000 100%Siegfried Biologics AG, Zofingen CHF 100’000 100%Siegfried Generics International AG, Zofingen CHF 2 000 000 100%Siegfried Finance AG, Zofingen CHF 14 000 000 100%Siegfried Dienste AG, Zofingen CHF 10 000 000 100%Sidroga AG, Zofingen CHF 1 000 000 100%Sigamed AG, Zug CHF 500 000 100%Sidroga Gesundheitsprodukte AG, Zofingen CHF 200'000 100%2. EuropeSiegfried GmbH, Munich EUR 25’000 100%Siegfried Biologics GmbH, D-Kleinmachnow EUR 69 000 100%Siegfried Generics (Malta) Ltd, Valletta EUR 100 000 100%Siegfried Deutschland Holding GmbH, EUR 1 790 000 100%Bad SäckingenSidroga GmbH, Bad Säckingen EUR 256 000 100% 75% held by SiegfriedDeutschland Holding GmbHSidroga Handels GmbH, Wien EUR 35 000 100% 100% held bySidroga Gesundheitsprodukte AG,ZofingenSiegfried Immobilien GmbH, Bad Säckingen EUR 52 000 100% 100 % held by SiegfriedDeutschland Holding GmbHSiegfried B.V., Amsterdam EUR 80 000 100% Paid-in nominal capital:NLG 35 000 (20%)3. North and Central AmericaSiegfried (USA), Inc., Pennsville USD 500 000 100%Atlantis SA, Mexico MXN 3 000 000 20% not consolidatedPenick Holding Company, Pennsville USD 2 100%Penick Corporation, Pennsville USD 0 100%4. AsiaSCI Pharmtech Inc., Taiwan TWD 200 000 000 16.66% not consolidatedCorporate Governance27
4. Shareholders4.1 Major shareholdersThe following table describes the shareholder structure ofSiegfried Holding AG and lists shareholders reportingholdings of 3% or more of the voting rights of SiegfriedHolding AG In addition, the shareholdings of the Boardof Directors and of the Group Management are shown.The Camellia Group and the Siegfried Shareholders Grouphave granted each other the right of first refusal relative tothe sale of shares held by them.Shareholders Shares held as of 31.12.2006 % Shares held as of 31.12.2005 %With holdings over 3%Camellia Group 933 680 33.35 933 680 33.35(consisting of CamelliaHolding AG, Glarus;Affish Ltd, Linton)Siegfried Shareholders’ Group (consisting of 145 335 5.19 151 051 5.39descendants of Dr hc Hans Siegfriedand Sigamed AG, Zug)Tweedy, Browne Company LLC, New York 1 287 532 10.27 287 532 10.273V Asset Management AG, Zürich 2 89 000 3.18Total 1 455 547 51.99 1 372 263 49.01Board of Directors and Group ManagementBoard of Directors, non-executive 3 16 078 0.57 18 440 0.66Board of Directors, executive and Group Management 4 767 0.17 700 0.02Total 20 845 0.74 19 140 0.68OtherPublic shareholders 1 320 672 47.17 1 404 810 50.17Shares held by Siegfried Holding AG 2 936 0.10 3 787 0.14Total 1 323 608 47.27 1 408 597 50.31Grand total 2 800 000 100 2 800 000 1001By its own account, Tweedy, Browne LLC, New York held 10.27% of theshares of Siegfried Holding AG as of 12/31/2005. The Board of Directorsrecorded 3% of these shares as voting rights, the rest without voting rights.23% of these shares were registered as voting rights.3Excluding the shareholdings of Dr Bernard A. Siegfried, which are includedin the position “Siegfried Shareholders’ Group”.28 Corporate Governance
Page 1 and 2: Siegfried - when substance mattersA
Page 3 and 4: OverviewFor 2006, the Siegfried Gro
Page 6 and 7: Sabrina BaumannChemical Lab Apprent
Page 8 and 9: custom synthesis and shorten projec
Page 10: we are obligated to maintain our in
Page 13 and 14: Annual ReportThe Siegfried Division
Page 15 and 16: apid change as significant price er
Page 17 and 18: The Siegfried Division PipelineThe
Page 19 and 20: The Sidroga DivisionThe Sidroga Div
Page 21 and 22: OutlookThe revenues for active phar
Page 23 and 24: Board of Directors and Corporate Of
Page 26 and 27: Adrian AzzopardiQuality Control Man
Page 28 and 29: 2. Foreword and general frameworkRe
Page 32 and 33: 4.2 CrossholdingsThe Siegfried Grou
Page 34 and 35: 6.2 ProfilesDr Markus Altwegg, Chai
Page 36 and 37: Prof Dr med Felix GutzwillerFelix G
Page 38 and 39: 6.3 Linking directorates6.3.1 Corpo
Page 40 and 41: Excerpt from the company regulation
Page 42 and 43: 7.2 ProfilesDouglas C. Günthardt,
Page 44 and 45: 7.3 Management ContractsSiegfried H
Page 46 and 47: 9.3 Calling a General Meeting of Sh
Page 48: 12. Information policyThe Siegfried
Page 51 and 52: Report on“Safety - Health - Envir
Page 53 and 54: Overview 2002-2006Key corporate fig
Page 55 and 56: Resources2002-2006 overviewUnit 200
Page 57 and 58: Workplace accidentsComparison: 2002
Page 60 and 61: Paul GauvreauProcess Development Ch
Page 62 and 63: Net profits declined from CHF 36.5
Page 64 and 65: Consolidated Income Statementfor th
Page 66 and 67: Consolidated Statement of Recognize
Page 68 and 69: Restated Recognized Income and Expe
Page 70 and 71: asset in question is reviewed and,
Page 72 and 73: Research and development Research a
Page 74 and 75: Financial Statements Siegfried Grou
Page 76 and 77: 2. Property, plant and equipmentIn
Page 78 and 79: The recoverability of capitalized G
Page 80 and 81:
8. Other current assetsIn 1000 CHF
Page 82 and 83:
The financial liabilities are denom
Page 84 and 85:
The following amounts are recognize
Page 86 and 87:
Contingent liabilities for addition
Page 88 and 89:
Report of the Group auditorsto the
Page 90:
Financial Statements Siegfried Grou
Page 93 and 94:
Financial Statements Siegfried Hold
Page 95 and 96:
Securities are stated at the lower
Page 97 and 98:
Stock market data2006 2005 2004 200
Page 99 and 100:
Cautionary statement regarding forw
show all

English - Siegfried

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?